Position in PHVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$227,027,105
+$49,490,772 QoQ
Shares Held
6,565,272
+4.5% QoQ
Ownership
9.35%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 124 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. PHVS ranks #64 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in PHVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,027,105 | 6,565,272 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $177,536,333 | 6,284,472 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $177,576,634 | 6,399,158 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $159,658,991 | 6,399,158 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $95,434,116 | 5,422,393 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $84,707,309 | 5,395,370 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $103,429,242 | 5,395,370 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $96,408,748 | 5,205,656 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $97,866,332 | 5,205,656 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $120,009,860 | 5,192,984 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $145,663,199 | 5,192,984 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $66,941,859 | 3,207,564 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $51,281,556 | 3,387,157 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,704,241 | 3,315,238 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $37,296,427 | 3,315,238 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $25,427,491 | 3,315,188 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $73,265,654 | 3,315,188 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $60,120,934 | 3,315,188 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $47,416,617 | 3,295,109 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $58,736,989 | 3,312,859 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $60,700,582 | 3,258,217 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $77,441,001 | 2,767,727 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||